Terms: = Germ cell tumor AND PIM1, PIM, 5292, ENSG00000137193, P11309 AND Prognosis
5 results:
1. DNA methylation heterogeneity attributable to a complex tumor immune microenvironment prompts prognostic risk in glioma.
Ma S; Pan X; Gan J; Guo X; He J; Hu H; Wang Y; Ning S; Zhi H
Epigenetics; 2024 Dec; 19(1):2318506. PubMed ID: 38439715
[TBL] [Abstract] [Full Text] [Related]
2. Metabolic-related gene pairs signature analysis identifies ABCA1 expression levels on tumor-associated macrophages as a prognostic biomarker in primary IDH
Wang S; Li L; Zuo S; Kong L; Wei J; Dong J
Front Immunol; 2022; 13():869061. PubMed ID: 36248907
[TBL] [Abstract] [Full Text] [Related]
3. pim kinases mediate resistance of glioblastoma cells to TRAIL by a p62/SQSTM1-dependent mechanism.
Serrano-Saenz S; Palacios C; Delgado-Bellido D; López-Jiménez L; Garcia-Diaz A; Soto-Serrano Y; Casal JI; Bartolomé RA; Fernández-Luna JL; López-Rivas A; Oliver FJ
Cell Death Dis; 2019 Jan; 10(2):51. PubMed ID: 30718520
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells.
Frömberg A; Rabe M; Oppermann H; Gaunitz F; Aigner A
BMC Cancer; 2017 Jan; 17(1):3. PubMed ID: 28049521
[TBL] [Abstract] [Full Text] [Related]
5. pim1 kinase is upregulated in glioblastoma multiforme and mediates tumor cell survival.
Herzog S; Fink MA; Weitmann K; Friedel C; Hadlich S; Langner S; Kindermann K; Holm T; Böhm A; Eskilsson E; Miletic H; Hildner M; Fritsch M; Vogelgesang S; Havemann C; Ritter CA; Meyer zu Schwabedissen HE; Rauch B; Hoffmann W; Kroemer HK; Schroeder H; Bien-Möller S
Neuro Oncol; 2015 Feb; 17(2):223-42. PubMed ID: 25155357
[TBL] [Abstract] [Full Text] [Related]
